Stay updated with breaking news from Polypid Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
03.01.2022 - Current EVP & CFO, Dikla Czaczkes Akselbrad, Appointed CEO, Effective July 2022PETAH TIKVA, Israel, Jan. 03, 2022 (GLOBE NEWSWIRE) - PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a Phase 3 biopharmaceutical company focused on ... Seite 1
In this article, we discuss the 10 micro-cap stocks to buy according to Cathie Wood.
PolyPid Ltd (NASDAQ: PYPD) has received written responses from the FDA to a Type B meeting request that the company submitted regarding its ...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) ...
Surgical Site Infection Market Size to Grow Remarkably with a CAGR of 22.84% for the Study Period (2018-2030), Predicts DelveInsight due to the launch of emerging therapies and increased surgical interventions due to several causes LAS VEGAS, April 28, 2021 /PRNewswire/ -- DelveInsight's " Surgical Site Infection Market" report provides a thorough comprehension of the Surgical Site Infection, historical and forecasted epidemiology, and the Surgical Site Infection market trends in the 7MM [the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan]. The Surgical Site...